Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania.

Abstract

Magnesium sulfate (MgSO4) is used to treat and prevent eclamptic seizures, and several anticonvulsant drugs (e.g., sodium valproate) are clinically effective antimanic drugs. Psychostimulant-induced hyperlocomotion has been proposed as an animal model for the study of antimanic drugs. The present study evaluated the effects of MgSO4 and sodium valproate (as a positive control) on hyperlocomotion induced by methylphenidate in mice. Acute MgSO4 (300-400 mg/kg), but not sodium valproate (100-300 mg/kg), prevented the increase in locomotor activity induced by methylphenidate (5.0 mg/kg). In contrast, repeated treatment (14 days) with valproate (300 mg/kg), but not MgSO4 (400 mg/kg), blocked methylphenidate-induced hyperlocomotion. Thus, acute MgSO4 exerted antimanic-like effects in this animal model.

Extracted Key Phrases

Statistics

050100201220132014201520162017
Citations per Year

58 Citations

Semantic Scholar estimates that this publication has 58 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Barbosa2011MagnesiumSA, title={Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania.}, author={Francisco Jaime Barbosa and Bernardete Hesse and Rodrigo Bonifx00E1cio de Almeida and Irin{\'e}ia Paulina Baretta and Roseli Boerngen-Lacerda and Roberto Andreatini}, journal={Pharmacological reports : PR}, year={2011}, volume={63 1}, pages={64-70} }